High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease

Medicina Oral, Patologia Oral y Cirugia Bucal

Volumn 15, Issue 6, 2010, Pages

  Ardila, Carlos M ^a   López, Mayra A ^a   Guzmán, Isabel C ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

Antibiotics; Antimicrobial activity; Resistance

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; CLINDAMYCIN; METRONIDAZOLE; MOXIFLOXACIN;

ADULT; AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATE; CHEMICAL ANALYSIS; CHRONIC PERIODONTITIS; EPSILOMETER TEST; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PATHOGENESIS; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS;

ACTINOBACILLUS ACTINOMYCETEMCOMITANS; AMOXICILLIN; ANTI-INFECTIVE AGENTS; CLINDAMYCIN; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METRONIDAZOLE; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS;

EID: 78649716008     PISSN: 16984447     EISSN: 16986946     Source Type: Journal    
DOI: 10.4317/medoral.15.e947     Document Type: Article

References (20)

1. Friedewald VE, Kornman KS, Beck JD, Genco R, Goldfine A, Libby P, et al. The American Journal of Cardiology and Journal of Periodontology editors' consensus: periodontitis and atherosclerotic cardiovascular disease. J Periodontol. 2009;80:1021-32.
2. Tribble GD, Lamont GJ, Progulske-Fox A, Lamont RJ. Conjugal transfer of chromosomal DNA contributes to genetic variation in the oral pathogen Porphyromonas gingivalis. J Bacteriol. 2007;189:6382-8.
3. Fives-Taylor PM, Meyer DH, Mintz KP, Brissette C. Virulence factors of Actinobacillus actinomycetemcomitans. Periodontol 2000. 1999;20:136-67.
4. Rudney JD, Chen R, Sedgewick GJ. Intracellular Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in buccal epithelial cells collected from human subjects. Infect Immun. 2001;69:2700-7. (Pubitemid 32239747)
5. Bartlett JG, O'Keefe P, Tally FP, Louie TJ, Gorbach SL. Bacteriology of hospital-acquired pneumonia. Arch Intern Med. 1986;146:868-71.
6. Walker C, Karpinia K. Rationale for use of antibiotics in periodontics. J Periodontol. 2002;73:1188-96.
7. Guentsch A, Jentsch H, Pfister W, Hoffmann T, Eick S. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. J Periodontol. 2008;79:1894-903.
8. Van Winkelhoff AJ, Herrera D, Oteo A, Sanz M. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain. J Clin Periodontol. 2005;32:893-8. (Pubitemid 41008329)
9. Herrera D, Contreras A, Gamonal J, Oteo A, Jaramillo A, Silva N, et al. Subgingival microbial profiles in chronic periodontitis patients from Chile, Colombia and Spain. J Clin Periodontol. 2008;35:106-13.
10. Mosca A, Miragliotta L, Iodice MA, Abbinante A, Miragliotta G. Antimicrobial profiles of Prevotella spp. and Fusobacterium nucleatum isolated from periodontal infections in a selected area of southern Italy. Int J Antimicrob Agents. 2007;30:521-4.
11. Valenzuela MT, de Quadros C. Antibiotic resistance in Latin America: a cause for alarm. Vaccine. 2009;27 Suppl 3:C25-8.
12. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1-6.
13. Möller AJ. Microbiological examination of root canals and periapical tissues of human teeth. Methodological studies. Odontol Tidskr. 1966;74:1-380.
14. Slots J. Rapid identification of important periodontal microorganisms by cultivation. Oral Microbiol Immunol. 1986;1:48-57.
15. Ambler J, Rennie R, Poupard J, Koeth L, Stass H, Endermann R, et al. Determination of moxifloxacin anaerobic susceptibility breakpoints according to the Clinical and Laboratory Standards Institute guidelines. Diagn Microbiol Infect Dis. 2008;61:49-57.
16. Moet GJ, Jones RN, Biedenbach DJ, Stilwell MG, Fritsche TR. Contemporary causes of skin and soft tissue infections in North America, Latin America, and Europe: report from the SENTRY Antimicrobial Surveillance Program (1998-2004). Diagn Microbiol Infect Dis. 2007;57:7-13.
17. Kulik EM, Lenkeit K, Chenaux S, Meyer J. Antimicrobial susceptibility of periodontopathogenic bacteria. J Antimicrob Chemother. 2008;61:1087-91.
18. Brescó-Salinas M, Costa-Riu N, Berini-Aytés L, Gay-Escoda C. Antibiotic susceptibility of the bacteria causing odontogenic infections. Med Oral Patol Oral Cir Bucal. 2006;11:E70-5.
19. Eick S, Pfister W, Straube E. Antimicrobial susceptibility of anaerobic and capnophilic bacteria isolated from odontogenic abscesses and rapidly progressive periodontitis. Int J Antimicrob Agents. 1999;12:41-6. (Pubitemid 29241823)
20. Madinier IM, Fosse TB, Hitzig C, Charbit Y, Hannoun LR. Resistance profile survey of 50 periodontal strains of Actinobacillus actinomyectomcomitans. J Periodontol. 1999;70:888-92. (Pubitemid 29400113)